Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02296723 | Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition | PHASE1 | COMPLETED | 66 | — | — | Jul 1, 2011 | Aug 1, 2011 | Nov 20, 2014 | 1 | India |
| NCT02297854 | Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition | PHASE1 | COMPLETED | 83 | — | — | Jul 1, 2011 | Aug 1, 2011 | Nov 21, 2014 | 1 | India |
| Arm | Type | Description |
|---|---|---|
| Valganciclovir Hydrochloride Tablets 450 mg | EXPERIMENTAL | Valganciclovir Hydrochloride Tablets 450 mg of Dr. Reddys Laboratories Limited |
| Valcyte | ACTIVE_COMPARATOR | Valcyte® 450 mg tablets of Genentech USA Inc., Sanfrancisco |
| Name | Type | Description |
|---|---|---|
| Valganciclovir Hydrochloride | DRUG | Valganciclovir Hydrochloride Tablets 450 mg |
Inclusion Criteria: * Healthy, adult, human volunteers between 18 to 55 years of age (both inclusive) living in and around Ahmedabad city or western part of lndia * Having a Body Mass Index (BMD between 18.5 - 24.9 (both inclusive), calculated as weight in kg / height in meter2 * Not having any sig...